Matthew Freiberg

August 5, 2022

Study that investigated whether three smoking cessation drugs could reduce alcohol intake yields unexpected finding

A Vanderbilt study of three proven smoking cessation treatments suggests these medications could play an important role to reduce alcohol use and smoking at the same time.

By Tom Wilemon
February 3, 2022

Team to study using probiotics to reduce heart disease risk

A Vanderbilt research team has received a $7 million grant from the National Institutes of Health (NIH) to understand how alcohol’s effect on the gut microbiome drives heart disease.

By Matt Batcheldor
June 24, 2020

Study finds zinc doesn’t reduce mortality, other health risks, for heavy alcohol users living with HIV/AIDS

Zinc supplementation did not reduce mortality, cardiovascular risk, levels of inflammation or microbial translocation among people with heavy alcohol use living with HIV/AIDS, according to a Vanderbilt-led study.

By Matt Batcheldor
July 18, 2019

Genetic characteristics of peripheral artery disease studied

New study explores why some people with peripheral artery disease present with problems with their legs, some with their heart and some with strokes.

By Matt Batcheldor
HIV virus
September 20, 2018

New HIV research training program launched

With the help of a $1.6 million grant from the National Heart, Lung and Blood Institute, Vanderbilt University Medical Center is launching a specialized research training program called Vanderbilt Scholars in HIV and Heart, Lung, Blood and Sleep Research, or V-SCHoLARs.

By Paul Govern
May 29, 2018

New research finds lung cancer risk drops substantially within five years of quitting smoking

Just because you stopped smoking years ago doesn’t mean you’re out of the woods when it comes to developing lung cancer.  That’s the “bad” news. The good news is your risk of lung cancer drops substantially within five years of quitting.

By Bill Snyder
May 3, 2018

Six Vanderbilt physicians honored by medical societies

Four faculty members of Vanderbilt University School of Medicine were among 78 physician-scientists inducted into The American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry. They are:
By Bill Snyder
April 27, 2017

HIV-infected people have higher risk of heart failure

The first large study to report that HIV-infected people have a significantly higher risk of heart failure in the antiretroviral therapy era has been published in JAMA Cardiology.
By Jessica Pasley
October 8, 2015

Depression poses heart risk for HIV patients: study

The first study to suggest that major depressive disorder (MDD) is an independent risk factor for heart failure in HIV-positive adults has been published in Circulation.
By Kathy Whitney